Medical Devices Today

Former CDRH Director Joins Upcoming Webinar Panel

D. Bruce Burlington, M.D., Former Director of the Center for Devices and Radiological Health (CDRH), will join a FDC Reports and Windhover sponsored webinar called The Road to FDA Approval: Advisory Committee Survival Strategies on Tuesday, July 10, 2008.

VCs Keep Capital Flowing To Stent Start-Ups

Article preview from Start-Up - May 2008

Venture capital investments in stent companies have remained strong over the past three years. According to Windhover's Strategic Transactions Database, VCs invested more than $114 in stent start-ups last year, compared with $31 million in 2006 and $70 million in 2007.

European Markets for Benign Prostatic Hyperplasia Drugs, Devices and Therapies

Report preview from Medtech Insight - Published June 2008

The European market for BPH treatment products, including drugs and minimally invasive therapies, was valued at approximately $718.1 million in 2007. Sales of BPH treatment products in Europe are expected to increase at a compound annual rate of 4.5%, reaching an estimated $857.0 million in the year 2011. Find out about the most promising drug therapies and minimally invasive energy-based treatments on the horizon.

Spotlight On Early-Stage Cardio Vascular and Peripheral Vascular Medical Technology Companies

SAN FRANCISCO - Medical Devices Today has put together an exclusive roundup of the 10 early-stage cardio vascular and peripheral vascular medical technology companies that presented at the "Investment In Innovation (In3) Medical Device Summit" on June 17-19, 2008. (Part 1 of 3)

ClinicalTrials.gov Requirements Continue To Baffle Firms And Feds Alike

Full article reprinted from "The Gray Sheet" - June 23, 2008

Device companies are not the only ones tripped up by the new ClinicalTrials.gov trial registration requirements, as FDA, NIH and others struggle to define what is and is not subject to the law.

To Avoid European Dawn Raids, Keep Competitive Practices Clean – Lawyers

Full article reprinted from "The Gray Sheet" - June 23, 2008

Find out why device companies operating in Europe should develop internal plans to avoid "dawn raids" by the European Commission or a national competition authority aimed at investigating potential anti-competitive practices.

CMS Fields Comments On Who Should Have Bariatric Surgery For Diabetes

Article preview from "The Gray Sheet" - June 23, 2008

Find out why endocrinologists are cautioning CMS against making any immediate policy changes on how Medicare covers bariatric surgery to treat diabetes.

Eisai Transfers Medical Device Subsidiary To Terumo

Full brief reprinted from PharmAsia News - June 26, 2008

Eisai announced June 19 that the company signed an agreement with Terumo to transfer all shares of Clinical Supply, a Eisai subsidiary that manufactures and markets medical devices such as catheters. Within 30 days, Eisai will transfer 84.8 percent of Clinical Supply shares to Terumo, which is strengthening its catheter business. No details on the deal's price were disclosed. (Click here for more - Japanese language)

"Eisai Transfers Medical Device Subsidiary Shares To Terumo" - Jiji Press News (6/19/08)

Start your 30-day, risk-free trial of PharmAsia News today!

Takes a Saint

Article preview from the IN VIVO BLOG - June 26, 2008

Lost in the news that Boston Scientific is continuing to sell off pieces of itself was the creation of a new venture capital fund affiliated with secondary buyer Saints Capital.

Saints raised $165 million for new fund, Saints Everest. It paid $100 million for 54 companies from Boston Scientific's venture portfolio. Its investors include Adams Capital Management and Harbourvest Partners LLC, according to Scott Halsted, the firms' new managing director.

MDMA Inks Deal To Help Members Track Relationships

Full article reprinted from "The Gray Sheet" - June 23, 2008

As device makers ready themselves for stricter oversight of their relationships with doctors, the Medical Device Manufacturers Association has signed a partnership with a compliance consulting firm that will give MDMA members special access and discounts on compliance software tools and services.